Results 21 to 30 of about 63 (63)

L‐equivalence for degree five elliptic curves, elliptic fibrations and K3 surfaces

Bulletin of the London Mathematical Society, Volume 52, Issue 2, Page 395-409, April 2020., 2020
Abstract We construct non‐trivial L‐equivalence between curves of genus one and degree five, and between elliptic surfaces of multisection index five. These results give the first examples of L‐equivalence for curves (necessarily over non‐algebraically closed fields) and provide a new bit of evidence for the conjectural relationship between L ...
Evgeny Shinder, Ziyu Zhang
wiley   +1 more source

ORBIT PARAMETRIZATIONS FOR K3 SURFACES

Forum of Mathematics, Sigma, 2016
We study moduli spaces of lattice-polarized K3 surfaces in terms of orbits of representations of algebraic groups. In particular, over an algebraically closed field of characteristic 0, we show that in many cases, the nondegenerate orbits of a ...
MANJUL BHARGAVA, WEI HO, ABHINAV KUMAR
doaj   +1 more source

Hilbert Schemes Of Points On Some K3 Surfaces And Gieseker Stable Bundles

, 1996
. By using a Fourier-Mukai transform for sheaves on K3 surfaces we show that for a wide class of K3 surfaces X the Hilbert schemes Hilb n (X) can be identified for all n ? 1 with moduli spaces of Gieseker stable vector bundles on X. We also introduce a
Antony Maciocia, Bruzzo, Ugo, Maciocia, A., Bruzzo, U., Ugo Bruzzo   +4 more
core   +1 more source

Efficacy and field safety of ilunocitinib for the control of atopic dermatitis in client‐owned dogs: A multicentre, double‐masked, randomised, placebo‐controlled clinical trial

Veterinary Dermatology, Volume 36, Issue 5, Page 647-659, October 2025.
Background – Inhibition of the Janus kinase (JAK) pathway is a well‐established option for canine atopic dermatitis (cAD). Objective – To evaluate the efficacy and safety of ilunocitinib, a novel JAK inhibitor for the control of pruritus and skin lesions in client‐owned dogs with cAD.
Sophie Forster, Candace M. Trout, Simona Despa, Annette Boegel, Darren Berger, Stephen King   +5 more
wiley   +1 more source

Immunotherapy using pullulan‐conjugated Der f 2 allergen in canine atopic dermatitis: An anti‐inflammatory agent‐sparing approach

Veterinary Dermatology, Volume 36, Issue 4, Page 443-452, August 2025.
Background – Allergen immunotherapy is used as aetiological treatment for canine atopic dermatitis (cAD). Objective – To assess the anti‐inflammatory agent‐sparing effect over 1 year of immunotherapy using pullulan‐conjugated recombinant Der f 2 (rDf2‐P). Conclusions and Clinical Relevance – Der f 2‐P immunotherapy can lead to a rapid reduction in anti‐
Masahiko Nagata, Jin Kozakai, Aya Yoshida, Kana Kameyama, Hiromi Oboso, Hisanori Muto, Shoji Ogino, Toshihiro Tsukui   +7 more
wiley   +1 more source

Moduli stacks of polarized K3 surfaces in mixed characteristic [PDF]

, 2006
2000 Mathematics Subject Classification: 14J28, 14D22.In this note we define moduli stacks of (primitively) polarized K3 spaces. We show that they are representable by Deligne-Mumford stacks over Spec(Z).
Rizov, Jordan
core  

Rank jumps and multisections of elliptic fibrations on K3 surfaces

Forum of Mathematics, Sigma
We consider the countably many families $\mathcal {L}_d$ , $d\in \mathbb {N}_{\geq 2}$ , of K3 surfaces admitting an elliptic fibration with positive Mordell–Weil rank. We prove that the elliptic fibrations on the very general member of these
Alice Garbagnati, Cecília Salgado
doaj   +1 more source

Comparative efficacy and safety of ilunocitinib and oclacitinib for the control of pruritus and associated skin lesions in dogs with atopic dermatitis

Veterinary Dermatology, Volume 36, Issue 2, Page 165-176, April 2025.
Background – Janus kinase inhibitors (JAKi) have been shown to reduce pruritus and improve associated inflammatory skin lesions in canine atopic dermatitis (cAD). Objective – To evaluate the efficacy and safety of ilunocitinib, in comparison to oclacitinib, for the control of cAD in a randomised, blinded trial.
Sophie Forster, Annette Boegel, Simona Despa, Candace Trout, Stephen King   +4 more
wiley   +1 more source

Treatment of moderate‐to‐severe canine atopic dermatitis with modified‐release mycophenolate (OKV‐1001): A pilot open‐label, single‐arm multicentric clinical trial

Veterinary Dermatology, Volume 35, Issue 6, Page 652-661, December 2024.
Background – Mycophenolate is an immunomodulating agent successfully used for the treatment of moderate‐to‐severe atopic dermatitis (AD) in people. Mycophenolate is an effective steroid‐sparing treatment option for use in dogs with inflammatory skin diseases.
Michael Klotsman, Wayne H. Anderson, Danielle Wyatt, Tom Lewis, Natalie Theus, Domenico Santoro   +5 more
wiley   +1 more source

Efficacy and safety of a hydrocortisone aceponate‐containing ear spray solution in dogs with erythemato‐ceruminous otitis externa: A randomised, multicentric, single‐blinded, controlled trial

Veterinary Dermatology, Volume 35, Issue 2, Page 197-206, April 2024.
Background – Erythemato‐ceruminous otitis externa (ECOE) is frequently seen in dogs affected with an allergic skin disease, with recurrent secondary bacteria and yeast overgrowths (detected on cytological examination). Objectives – The objective of the study was to compare the efficacy and safety of an ear spray containing only hydrocortisone aceponate
Delphine Rigaut, Philippe Briantais, Pierre Jasmin, Alice Bidaud   +3 more
wiley   +1 more source